Page 5 - Gild Into News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Gild into. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Gild Into Today - Breaking & Trending Today

Brighton Jones LLC Reduces Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)

Brighton Jones LLC decreased its holdings in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 9.0% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 12,152 shares of the biopharmaceutical company’s stock after selling 1,197 shares during the quarter. Brighton Jones LLC’s holdings in Gilead Sciences were worth $984,000 at the […] ....

United Kingdom , United States , Brighton And Hove , Merdad Parsey , Complera Eviplera , Cantor Fitzgerald , Holdings Channel , News Ratings For Gilead Sciences Daily , Gilead Sciences , Bailard Inc , International Assets Investment Management , Gilead Sciences Announces Dividend , Gilead Sciences Trading , Wells Fargo Company , Brighton Jones , Clearbridge Investments , Quarter For Gilead Sciences , Insider Transactions At Gilead Sciences , United Kingdom Plc , Gilead Sciences Inc , Free Report , Assets Investment Management , Kingdom Plc , Get Free Report , Visit Holdingschannel , Gilead Sciences Daily ,

Gilead Sciences (NASDAQ:GILD) Price Target Lowered to $85.00 at Maxim Group

Gilead Sciences (NASDAQ:GILD – Get Free Report) had its price objective reduced by equities research analysts at Maxim Group from $90.00 to $85.00 in a research note issued on Wednesday, Briefing.com reports. The brokerage presently has a “buy” rating on the biopharmaceutical company’s stock. Maxim Group’s target price suggests a potential upside of 30.37% from […] ....

United States , New Zealand General , New Zealand , Merdad Parsey , Complera Eviplera , Insider Transactions At Gilead Sciences , Gilead Sciences Stock Down , Cantor Fitzgerald , Norges Bank , Gilead Sciences Inc , News Ratings For Gilead Sciences Daily , Securities Exchange Commission , Analyst Recommendations For Gilead Sciences , Wellington Management Group , Morgan Stanley , Maxim Group , Capital Research Global Investors , Wells Fargo Company , Institutional Trading Of Gilead Sciences , Needham Company , Gilead Sciences , Get Free Report , Sciences Stock Down , Exchange Commission , World Investors , Research Global Investors ,

Gilead Sciences (NASDAQ:GILD) Given New $74.00 Price Target at Royal Bank of Canada

Gilead Sciences (NASDAQ:GILD – Free Report) had its target price lowered by Royal Bank of Canada from $76.00 to $74.00 in a research note issued to investors on Friday morning, Benzinga reports. The brokerage currently has a sector perform rating on the biopharmaceutical company’s stock. A number of other research analysts also recently issued reports […] ....

United States , Complera Eviplera , Merdad Parsey , Nilsine Partners , Gilead Sciences , Gilead Sciences Inc , News Ratings For Gilead Sciences Daily , Gilead Sciences Company Profile , Gilead Sciences Trading , Institutional Investors Weigh In On Gilead Sciences , Royal Bank , Financial Counselors Inc , Analyst Recommendations For Gilead Sciences , Wealth Partners , Etesian Wealth Advisors Inc , Institutional Family Asset Management , Cantor Fitzgerald , Gilead Sciences Dividend Announcement , Free Report , Get Free Report , Wealth Advisors , Family Asset Management , Gilead Sciences Daily , Nasdaq Gild , Lower Price Target , Royal Bank Of Canada ,

Cozad Asset Management Inc. Reduces Stake in Gilead Sciences, Inc. (NASDAQ:GILD)

Cozad Asset Management Inc. decreased its stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 4.4% during the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 69,658 shares of the biopharmaceutical company’s stock after selling 3,185 shares during the period. Cozad Asset Management Inc.’s holdings […] ....

United States , Complera Eviplera , Merdad Parsey , Capital Management , Gilead Sciences Inc , Royal Bank , Morgan Stanley , Gilead Sciences Stock Performance , Gilead Sciences , Quarter For Gilead Sciences , Cozad Asset Management Inc , Gilead Sciences Dividend Announcement , Northern Trust Corp , Associates Corp , News Ratings For Gilead Sciences Daily , Pacer Advisors Inc , Cozad Asset Management , Free Report , Asset Management , Trust Corp , Get Free Report , Truist Financial , Visit Holdingschannel , Gilead Sciences Daily , Nasdaq Gild , Sec Filings ,

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by Cozad Asset Management Inc.

Cozad Asset Management Inc. cut its holdings in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 4.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 69,658 shares of the biopharmaceutical company’s stock after selling 3,185 shares during […] ....

United States , United Kingdom , Complera Eviplera , Merdad Parsey , Securities Exchange Commission , United Kingdom Plc , Gilead Sciences Price Performance , Gilead Sciences Profile , Bailard Inc , Gilead Sciences Inc , Exchange Commission , News Ratings For Gilead Sciences Daily , Gilead Sciences , International Assets Investment Management , Clearbridge Investments , Cantor Fitzgerald , Gilead Sciences Dividend Announcement , Quarter For Gilead Sciences , Cozad Asset Management Inc , Cozad Asset Management , Free Report , Asset Management , Assets Investment Management , Kingdom Plc , Get Free Report , Visit Holdingschannel ,